Mark Feinberg

Dr. Mark Feinberg is the President and CEO of the International AIDS Vaccine Initiative (IAVI) where he leads a global team of scientists, vaccine developers and clinical investigators working to ensure development of a safe, effective, and accessible HIV vaccine for use throughout the world. Mark has been actively involved in basic, translational and clinical research efforts focusing on HIV and other emerging infectious diseases for more than 30 years, and has held numerous leadership positions in academia, government and industry, championing innovative approaches for product development and delivery and forging impactful multi-sector partnerships. Prior to joining IAVI, Mark spent 11 years in leadership roles at Merck & Co., Inc., most recently as the Chief Public Health and Science Officer for Merck Vaccines. At Merck, he helped advance product development, medical and scientific policy efforts for innovative vaccines targeting, for example, rotavirus, human papillomavirus (HPV), shingles and HIV. In addition, he led a number of significant initiatives to enable Merck's R&D expertise to help address public health challenges impacting resource-poor countries, including the establishment of the MSD-Wellcome Trust Hilleman Laboratories, which focuses on the development of new and improved vaccines to address unmet needs in resource-limited countries. Most recently, Mark led efforts to coordinate a multi-sector partnership to expedite development of a promising Ebola vaccine candidate, rVSV-ZEBOV. Mark has previously served on the faculty of the University of California, San Francisco, and the Emory University School of Medicine; on the medical staff at San Francisco General Hospital and Grady Memorial Hospital in Atlanta, and as Medical Officer in the Office of AIDS Research at the National Institutes of Health (NIH). Mark currently serves as the Chair of the Interim Scientific Advisory Committee for the Coalition for Epidemic Preparedness Innovations (CEPI). Mark received his BA in Biology and Anthropology from the University of Pennsylvania and MD and PhD degrees from Stanford University. He completed postgraduate medical training at the Brigham and Women’s Hospital and a postdoctoral fellowship in the laboratory of David Baltimore at the Whitehead Institute. He is a Fellow of the American College of Physicians, and a member of the Association of American Physicians and the Council on Foreign Relations. Mark was a Fellow in the Advanced Leadership Initiative at Harvard University from 2012-2014.